Notes

In the competitive landscape of pharmaceutical development, impurity profiling plays a pivotal role in ensuring drug quality, safety, and regulatory compliance. Aquigen Bio now offers premium-grade impurity reference standards for:

https://aquigenbio.com/products/impurity-standards/padimate-o/

Pacritinib — a key JAK2/FLT3 inhibitor for myelofibrosis
Pafolacianine — an advanced fluorescent imaging agent used during surgical oncology interventions
These Certified Reference Materials (CRMs) are expertly designed to empower analytical teams engaged in method development, stability studies, pharmacokinetic analysis, and regulatory submissions.

Pacritinib Impurity Standards: Precision in Oncology Research
https://aquigenbio.com/products/impurity-standards/padimate-o/

Pacritinib — widely used in treating myelofibrosis and related hematologic malignancies — demands rigorous impurity control. Trace impurities can impact both efficacy and safety, necessitating quantification with high accuracy.

Aquigen Bio offers Pacritinib reference standards with full characterization, enabling seamless integration into LC-MS, HPLC, and other analytical platforms.
https://aquigenbio.com/products/impurity-standards/pacritinib/
These standards are ideal for:

Analytical method development & validation (AMV)
Quality control during ANDA filings
Ensuring measurement traceability to recognized pharmacopeias (USP/EP)
Pafolacianine Impurity Standards: Supporting Precision-Guided Surgery
Pafolacianine is critical in intraoperative imaging procedures — acting as a fluorescent marker to help surgeons identify malignant tissue. Its clinical impact demands impurity specifications that maintain consistent pharmacokinetic behavior and safety.

Aquigen Bio’s providing Pafolacianine CRMs includes:

Comprehensive analytical characterization
Batch traceability to pharmacopeial standards
Fit-for-purpose use in method validation and quality monitoring
Why High-Quality Impurity Standards Matter
Analytical Integrity: Using well-characterized reference materials ensures validated methods produce reliable, reproducible results.
Regulatory Confidence: CRMs backed by robust Certificates of Analysis (CoAs) support compliance with agencies like FDA and EMA.
Risk Reduction: Accurate impurity profiling protects patients by identifying trace-level impurities early in development.
Operational Efficiency: Ready-to-use standards accelerate workflows and minimize instrument downtime.
Aquigen Bio: Empowering Global Pharma Innovation
Aquigen Bio is a trusted provider of impurity standards, offering over 35,000 catalogued options for R&D and regulatory labs worldwide. Their impurity materials are fully documented, globally compliant, and shipped with expert guidance.

Call to Action
Elevate your analytical capabilities with premium impurity reference standards:

Download CoAs or request samples directly from Aquigen Bio’s online catalog.
Streamline method validation, bolster regulatory readiness, and ensure patient safety.
Learn more about Aquigen Bio’s impurity standards for Pacritinib and Pafolacianine, and access global support:
Aquigen Bio — aquigenbio.com